How to Cite
Abstract
The issue of how to deal with cannabis and related substances, the increase in their use and supply, and the associated consequences and problems, is a matter of much debate and has figured prominently in the international drug control debate in recent years.
References
World Drug Report 2022, Booklet 3, Drug Market Trends: Cannabis and Opioids (United Nations publication, 2022).
Tom Decorte and Gary R. Potter, The Global Cannabis Cultivation Research Consortium (GCCRC): A Transnational Online Survey of Cannabis Growers, EMCDDA Insights Series, vol. No. 26 (Luxembourg, Publications Office of the European Union, 2022).
World Drug Report 2022, Booklet 3.
Jakob Manthey and others, “Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates,” The Lancet Regional Health-Europe, vol. 10 (2021).
“Marijuana’s impact on California: 2020 – cannabis-related ER visits and admissions sky-rocket after medical and recreational marijuana laws,” Missouri Medicine, vol. 118, No.
(January/February 2021).
Koby Cohen and Aviv M. Weinstein, “Synthetic and non-synthetic cannabinoid drugs and their adverse effects: a review from public health perspective,” Frontiers in Public Health, vol. 6, art. No.162 (June 2018).